Roche Stock Forecast, Price & News

+0.50 (+1.05 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume417,571 shs
Average Volume835,869 shs
Market Capitalization$329.62 billion
P/E Ratio18.21
Dividend Yield1.60%
30 days | 90 days | 365 days | Advanced Chart
Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

Roche logo

About Roche

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.16 out of 5 stars

Medical Sector

399th out of 2,220 stocks

Pharmaceutical Preparations Industry

203rd out of 869 stocks

Analyst Opinion: 2.1Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Roche (OTCMKTS:RHHBY) Frequently Asked Questions

Is Roche a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 sell rating, 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Roche stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares.
View analyst ratings for Roche
or view top-rated stocks.

What stocks does MarketBeat like better than Roche?

Wall Street analysts have given Roche a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Roche wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Roche?

Roche saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 417,600 shares, a decline of 23.0% from the June 30th total of 542,500 shares. Based on an average trading volume of 1,865,000 shares, the days-to-cover ratio is presently 0.2 days.
View Roche's Short Interest

How has Roche's stock price been impacted by Coronavirus?

Roche's stock was trading at $40.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RHHBY shares have increased by 18.0% and is now trading at $48.26.
View which stocks have been most impacted by COVID-19

How often does Roche pay dividends? What is the dividend yield for Roche?

Roche announced a dividend on Friday, March 5th. Stockholders of record on Friday, March 19th will be given a dividend of $1.2782 per share on Monday, March 29th. This represents a dividend yield of 3.11%. The ex-dividend date of this dividend is Thursday, March 18th.
View Roche's dividend history

Is Roche a good dividend stock?

Roche pays an annual dividend of $0.77 per share and currently has a dividend yield of 1.60%. The dividend payout ratio of Roche is 29.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Roche will have a dividend payout ratio of 27.90% next year. This indicates that Roche will be able to sustain or increase its dividend.
View Roche's dividend history.

What price target have analysts set for RHHBY?

11 brokerages have issued 1 year price objectives for Roche's stock. Their forecasts range from $46.42 to $46.42. On average, they expect Roche's stock price to reach $46.42 in the next year. This suggests that the stock has a possible downside of 3.8%.
View analysts' price targets for Roche
or view top-rated stocks among Wall Street analysts.

Who are Roche's key executives?

Roche's management team includes the following people:
  • Severin Schwan, Chief Executive Officer & Executive Director
  • Alan Hippe, Chief Financial & Information Technology Officer
  • Urs Jaisli, Chief Compliance Officer
  • Per-Olof Attinger, Secretary-Executive Committee & Head-CEO Office
  • William Pao, Head-Pharma Research & Early Development

Who are some of Roche's key competitors?

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche's major shareholders?

Roche's stock is owned by a number of retail and institutional investors. Top institutional investors include Fisher Asset Management LLC (0.04%), Bristol John W & Co. Inc. NY (0.00%), Kornitzer Capital Management Inc. KS (0.00%), Hikari Power Ltd (0.00%), Schaper Benz & Wise Investment Counsel Inc. WI (0.00%) and Chartwell Investment Partners LLC (0.00%).

Which major investors are selling Roche stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS, Wendell David Associates Inc., Wallington Asset Management LLC, Patten & Patten Inc. TN, Cornerstone Investment Partners LLC, Lee Danner & Bass Inc., IFP Advisors Inc, and Fulton Bank N.A..

Which major investors are buying Roche stock?

RHHBY stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Bristol John W & Co. Inc. NY, Chartwell Investment Partners LLC, Opus Capital Group LLC, MAI Capital Management, Schaper Benz & Wise Investment Counsel Inc. WI, Hikari Power Ltd, and Rothschild Investment Corp IL.

How do I buy shares of Roche?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Roche's stock price today?

One share of RHHBY stock can currently be purchased for approximately $48.26.

How much money does Roche make?

Roche has a market capitalization of $329.62 billion and generates $64.54 billion in revenue each year. The company earns $15.25 billion in net income (profit) each year or $2.65 on an earnings per share basis.

How many employees does Roche have?

Roche employs 101,465 workers across the globe.

Does Roche have any subsidiaries?

The following companies are subsidiares of Roche: 454 Life Sciences, Adheron Therapeutics, Adheron Therapeutics Inc., Anadys Pharmaceuticals, Anadys Pharmaceuticals Inc., Ariosa Diagnostics, Ariosa Diagnostics Inc., Arius Research, Ascur Versicherungsvermittlungs GmbH, BINA Technology, Bina Technologies Inc., BioImagene, BioVeris, BioVeris Corporation, Biopharm AG, Boehringer Mannheim, Borean Pharma, Chemical Manufacturing and Trading Company Limited, Chugai Pharmaceutical Co. Ltd., Disetronic Holding AG, Dutalys GmbH, F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd / Jordan P.S.C., FLLC "Roche Products Limited", FMI Germany GmbH, Flatiron Health, Flatiron Health Inc., ForSight Labs, ForSight VISION4 Inc., Foundation Medicine, Foundation Medicine Inc., Foundation Medicine Securities Corporation, Galenus Mannheim Pharma GmbH, GeneWEAVE, GeneWEAVE Biosciences Inc., Genentech, Genentech Inc., Genentech P.R. Inc., Genentech USA Inc., Genia Technologies, Hoffmann - La Roche Ltd, Hoffmann-La Roche Inc., Hoffmann-La Roche Limited, Hoffmann-La Roche Products Limited, I5 Surviving Corp., IGEN International Inc., IGEN LS LLC, IQuum, IQuum Inc., Ignyta, Ignyta Inc., Inflazome, Infogenetik Moleküler Bilgi Hizmetleri Anonim Sirketi, Institut Roche SAS, InterMune, InterMune Holdings Limited, InterMune Inc., InterMune International AG, Jecure Therapeutics Inc., Kapa Biosystems, Kapa Biosystems (Pty) Ltd, Kapa Biosystems Inc., Limited Liability Company Roche Diabetes Care Rus, Limited Liability Company Roche Diagnostics Rus, MTM Laboratories, Marcadia Biotech, Medingo Ltd., Medingo Medical Solutions, Memory Pharmaceuticals, Memory Pharmaceuticals Corp., Mirus, Museum Tinguely AG, N.V. Roche S.A., P.T. Roche Indonesia, PVT Probenverteiltechnik GmbH, Phaor AG, Piramed, Productos Roche (El Salvador) S.A. de C.V., Productos Roche (Honduras) S.A., Productos Roche (Nicaragua) S.A., Productos Roche (Panama) S.A., Productos Roche Dominicana S.R.L., Productos Roche Guatemala (Sociedad Anónima), Productos Roche Interamericana S.A. (PRISA), Productos Roche Química Farmacéutica S.A., Productos Roche S.A., Productos Roche S.A. Química e Industrial, Productos Roche S.A. de C.V., Produtos Roche Químicos e Farmacêuticos S.A., Promedior, Rabbit-Air Ltd, RoDiagnostics Egypt for Trading S.A.E, Roche (China) Holding Ltd., Roche (Hellas) S.A., Roche (Hungary) Ltd, Roche (Malaysia) Sdn. Bhd., Roche (Philippines) Inc., Roche (Shanghai) Pharmaceuticals Consulting Co. Ltd, Roche (Shanghai) Pharmaceuticals Trading Co. Ltd., Roche - Moscow Ltd., Roche AB, Roche Algérie SPA, Roche Austria GmbH, Roche Bangladesh Limited, Roche Beteiligungs GmbH, Roche Biomedical Laboratories Inc., Roche Bolivia SRL., Roche Bulgaria EOOD, Roche Cameroun SARL, Roche Capital Market Ltd, Roche Capital Services Ltd., Roche Catalyst Investments Ltd., Roche Chemische Unternehmungen AG, Roche Chile Limitada, Roche Côte d’Ivoire SARL, Roche DC Japan K. K., Roche DC México S.A. de C.V., Roche Deutschland Holding GmbH, Roche Diabetes Care (Switzerland) Ltd, Roche Diabetes Care Argentina S.A., Roche Diabetes Care Asia Pacific Pte. Ltd., Roche Diabetes Care Australia Pty Limited, Roche Diabetes Care Austria GmbH, Roche Diabetes Care Brasil Ltda., Roche Diabetes Care Deutschland GmbH, Roche Diabetes Care France SAS, Roche Diabetes Care GmbH, Roche Diabetes Care Inc., Roche Diabetes Care India Private Limited, Roche Diabetes Care Italy S.p.A., Roche Diabetes Care Limited, Roche Diabetes Care Middle East FZCO, Roche Diabetes Care Nederland B.V., Roche Diabetes Care Polska sp. z o.o., Roche Diabetes Care South Africa Proprietary Limited, Roche Diabetes Care Spain S.L., Roche Diagnostica Brasil Ltda., Roche Diagnostics (Hellas) S.A., Roche Diagnostics (Hong Kong) Limited, Roche Diagnostics (Malaysia) Sdn. Bhd., Roche Diagnostics (Shanghai) Ltd., Roche Diagnostics (Suzhou) Limited, Roche Diagnostics (Switzerland) Ltd, Roche Diagnostics (Thailand) Limited, Roche Diagnostics Asia Pacific Pte. Ltd., Roche Diagnostics Australia Pty. Limited, Roche Diagnostics Belgium NV, Roche Diagnostics Corporation, Roche Diagnostics Deutschland GmbH, Roche Diagnostics France SAS, Roche Diagnostics GmbH, Roche Diagnostics Hematology Inc., Roche Diagnostics India Private Limited, Roche Diagnostics International Ltd, Roche Diagnostics K.K., Roche Diagnostics Korea Co. Ltd., Roche Diagnostics Limited, Roche Diagnostics Ltd., Roche Diagnostics Middle East FZCO, Roche Diagnostics NZ Limited, Roche Diagnostics Nederland B.V., Roche Diagnostics Norge A/S, Roche Diagnostics Operations Inc., Roche Diagnostics Oy, Roche Diagnostics Polska Sp. z o.o., Roche Diagnostics Proprietary Limited, Roche Diagnostics S.L., Roche Diagnostics S.p.A., Roche Diagnostics Scandinavia AB, Roche Diagnostics Turkey Anonim Sirketi, Roche Diagnostics a/s, Roche Ecuador S.A., Roche Eesti OÜ, Roche Egypt LLC, Roche Egypt for Manufacturing and Trading SAE, Roche Farma (Peru) S.A., Roche Farma S.A., Roche Farmacêutica Química Lda., Roche Finance Europe B.V., Roche Finance Ltd, Roche Financial Investments Ltd., Roche Financial Management Ltd., Roche Financial Services Ltd., Roche Forum Buonas Ltd, Roche Georgia LLC, Roche Glycart, Roche Glycart Ltd, Roche Health Solutions Inc., Roche Holding (UK) Limited, Roche Holdings Inc., Roche Hong Kong Limited, Roche Innovation Center Copenhagen A/S, Roche Innovatis, Roche International Ltd., Roche International Ltd. (Montevideo Branch), Roche Intertrade Limited, Roche Ireland Limited, Roche Kazakhstan LLP, Roche Kenya Limited, Roche Korea Company Ltd., Roche Laboratories Inc., Roche Latvija SIA, Roche Lebanon S.A.R.L., Roche Long Term Foundation, Roche Makedonija DOOEL, Roche Molecular Systems Inc., Roche Myanmar Company Limited, Roche Müstahzarlari Sanayi Anonim Sirketi, Roche Nederland B.V., Roche NimbleGen, Roche Norge A/S, Roche Operations Ltd., Roche Oy, Roche PVT GmbH, Roche Pakistan Limited, Roche Palo Alto LLC, Roche Pars Co. (Ltd.), Roche Pharma (Switzerland) Ltd, Roche Pharma AG, Roche Pharmaceuticals (Israel) Ltd., Roche Pharmaceuticals Middle East FZCO, Roche Pharmholding B.V., Roche Polska Sp. z o.o., Roche Privacy GmbH, Roche Products (India) Private Limited, Roche Products (Ireland) Limited, Roche Products (Mauritius) Ltd, Roche Products (New Zealand) Limited, Roche Products (Proprietary) Limited, Roche Products Ghana Limited, Roche Products Inc., Roche Products Limited, Roche Products Ltd., Roche Products Pty. Limited, Roche Products Saudi Arabia LLC, Roche R&D Center (China) Ltd., Roche Real Estate Services Mannheim GmbH, Roche Registration GmbH, Roche Registration Limited, Roche Romania S.R.L., Roche S.A., Roche S.p.A., Roche SAS, Roche Sequencing Solutions Inc., Roche Services (Asia Pacific) Sdn. Bhd., Roche Services (Europe) Ltd, Roche Services Americas Sociedad de Responsabilidad Limitada, Roche Services Holdings Ltd., Roche Servicios S.A., Roche Servicios de México S.A. de C.V., Roche Singapore Pte. Ltd., Roche Singapore Technical Operations Pte. Ltd., Roche Sistemas de Diagnósticos Sociedade Unipessoal Lda., Roche Slovensko S.R.O., Roche TCRC Inc., Roche Thailand Limited, Roche Tunisie SA, Roche Ukraine LLC, Roche Vietnam Company Limited, Roche a/s Medicinalvarer og Kemikalier, Roche d.o.o., Roche d.o.o. farmaceutsko drustvo – Roche Ltd. Pharmaceutical Company, Roche farmacevtska družba d.o.o., Roche mtm laboratories AG, Roche s.r.o., Santaris Pharma, Sapac Corporation Ltd., Seragon Pharmaceuticals Inc., Shanghai Roche Pharmaceuticals Limited, Signature Diagnostics GmbH, Spark Therapeutics, Spring Bioscience Corp., Stratos Genomics, Syntex Corporation, Syntex Pharm AG, Syntex Pharmaceuticals International Limited, Syntex Puerto Rico Inc., Tanox Inc., Tavero AG, Tensha Therapeutics, Tensha Therapeutics Inc., Therapeutic Human Polyclonals, Therapeutic Human Polyclonals Inc., Trophos, Trophos SA, Tusk Therapeutics, Tusk Therapeutics Limited, UAB Roche Lietuva, Ventana Medical Systems, Ventana Medical Systems Inc., Verum Diagnostica GmbH, Viewics, Viewics Inc., Viewics India Private Limited, mySugr, mySugr GmbH, and mySugr Inc..

When was Roche founded?

Roche was founded in 1896.

What is Roche's official website?

The official website for Roche is www.roche.com.

Where are Roche's headquarters?

Roche is headquartered at GRENZACHERSTRASSE 124, BASEL V8, CH-4070.

How can I contact Roche?

Roche's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at (161) 688-1111 or via email at [email protected]

This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.